The dynamic of pH, hydrogen peroxide and nitrite in exhaled breath condensate from patients with COPD and asthma exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
pH in exhaled breath condensate of patients with inflammatory airway diseases Source: Eur Respir J 2003; 22: Suppl. 45, 240s Year: 2003
Inflammatory cytokines in exhaled breath condensate (EBC) of exacerbated COPD patients Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008
Exhaled breath condensate pH Source: Eur Respir Monogr 2010; 49: 173-182 Year: 2010
Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008
8-isoprostane in breath condensate in patients with exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001
8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002
pH in expired breath condensate of patients with inflammatory airway diseases Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001
Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation Source: Eur Respir J 2004; 24: 1011-1017 Year: 2004
Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases Source: Annual Congress 2009 - Lung function in adults and children Year: 2009
Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005
N-acetylcysteine reduces 8-isoprostane levels in exhaled breath condensate and serum of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 13s Year: 2005
Concentrations of the hydrogen peroxide and nitrite in exhaled breath condensate as markers of inflammatory lung diseases Source: Annual Congress 2008 - COPD Year: 2008
Increased lactate concentrations in exhaled breath condensate (EBC) in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007
Lactate, pH and angiogenetic markers in exhaled breath condensate correlate with outcome and disease severity in patients with acute lung injury Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011
Increased IL-8 in exhaled breath condensate in cystic fibrosis during acute exacerbation Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001
Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004
Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008
Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008